BioNTech SE (BNTX)
87.44
+0.38
(+0.44%)
USD |
NASDAQ |
Oct 28, 11:16
BioNTech Market Cap : 21.97B for Oct. 28, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 27, 2026 | 21.87B |
| October 26, 2026 | 21.82B |
| October 23, 2026 | 22.13B |
| October 22, 2026 | 22.53B |
| October 21, 2026 | 22.93B |
| October 20, 2026 | 22.90B |
| October 19, 2026 | 22.41B |
| October 16, 2026 | 22.03B |
| October 15, 2026 | 22.66B |
| October 14, 2026 | 22.27B |
| October 13, 2026 | 22.36B |
| October 12, 2026 | 24.08B |
| October 09, 2026 | 24.36B |
| October 08, 2026 | 23.13B |
| October 07, 2026 | 23.93B |
| October 06, 2026 | 24.05B |
| October 05, 2026 | 24.53B |
| October 02, 2026 | 24.34B |
| October 01, 2026 | 24.33B |
| September 30, 2026 | 24.69B |
| September 29, 2026 | 24.76B |
| September 28, 2026 | 24.89B |
| September 25, 2026 | 24.75B |
| September 24, 2026 | 24.93B |
| September 23, 2026 | 24.73B |
| Date | Value |
|---|---|
| September 22, 2026 | 25.34B |
| September 21, 2026 | 24.62B |
| September 18, 2026 | 24.13B |
| September 17, 2026 | 24.78B |
| September 16, 2026 | 24.07B |
| September 15, 2026 | 24.29B |
| September 14, 2026 | 24.83B |
| September 11, 2026 | 24.30B |
| September 10, 2026 | 24.22B |
| September 09, 2026 | 24.65B |
| September 08, 2026 | 24.78B |
| September 04, 2026 | 26.06B |
| September 03, 2026 | 25.84B |
| September 02, 2026 | 26.08B |
| September 01, 2026 | 25.61B |
| August 31, 2026 | 25.52B |
| August 28, 2026 | 25.64B |
| August 27, 2026 | 27.98B |
| August 26, 2026 | 28.28B |
| August 25, 2026 | 28.65B |
| August 24, 2026 | 28.34B |
| August 21, 2026 | 29.28B |
| August 20, 2026 | 27.86B |
| August 19, 2026 | 28.42B |
| August 18, 2026 | 23.30B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Biodexa Pharmaceuticals Plc | 3.861B |
| Moderna, Inc. | 86.20B |
| Mereo BioPharma Group Plc | 46.94M |
| NuCana Plc | 4.698M |
| Immatics NV | 1.002B |
Market Cap Related Metrics
| PS Ratio | 6.997 |
| PEG Ratio | -0.0285 |
| Price to Book Value | 1.082 |
| Price to Free Cash Flow | 50.99 |
| Price | 87.44 |
| Earnings Yield | -8.97% |
| PEGY Ratio | -0.0285 |